References
1. Mulliken JB, Anupindi S, Ezekowitz RA, Mihm MC Jr. Case records of
the Massachusetts General Hospital. Weekly clinicopathological
exercises. Case 13-2004. A newborn girl with a large cutaneous lesion,
thrombocytopenia, and anemia. N Engl J Med. 2004;350:1764-75.
2. Croteau SE, Liang MG, Kozakewich HP, et al. Kaposiform
hemangioendothelioma: atypical features and risks of Kasabach-Merritt
phenomenon in 107 referrals. J Pediatr. 2013;162:142-7.
3. Ji Y, Chen S, Yang K, Xia C, Li L. Kaposiform hemangioendothelioma:
current knowledge and future perspectives. Orphanet J Rare Dis.
2020;15:39.
4. Sarkar M, Mulliken JB, Kozakewich HP, Robertson RL, Burrows PE.
Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is
associated with Kaposiform hemangioendothelioma and not with common
infantile hemangioma. Plast Reconstr Surg. 1997;100:1377-86.
5. Kasabach HH, Merritt KK. Capillary hemangioma with extensive purpura:
report of a case. Am J Dis Child. 1940;59:1063-70.
6. Enjolras O, Wassef M, Mazoyer E, et al. Infants with Kasabach-Merritt
syndrome do not have ”true” hemangiomas. J Pediatr. 1997;130:631-40.
7. Ryan C, Price V, John P, et al. Kasabach-Merritt phenomenon: a single
centre experience. Eur J Haematol. 2010;84:97-104.
8. Mahajan P, Margolin J, Iacobas I. Kasabach-Merritt Phenomenon:
Classic Presentation and Management Options. Clin Med Insights Blood
Disord. 2017;10:1179545X17699849.
9. Drolet BA, Trenor CC 3rd, Brandão LR, et al. Consensus-derived
practice standards plan for complicated Kaposiform hemangioendothelioma.
J Pediatr. 2013;163:285-91.
10. Cashell J, Smink GM, Helm K, Xavier F. Kaposiform
hemangioendothelioma with Kasabach-Merritt phenomenon in an
infant: Successful treatment with prednisolone, vincristine, and
addition of sirolimus. Pediatr Blood Cancer. 2018;65:e27305.